Using Evidence-Based Medicine to Support Clinical Decision-Making in RMS

Robert S Phillips; Bas Vaarwerk; Jessica E Morgan

doi:10.3390/cancers15010066

Using Evidence-Based Medicine to Support Clinical Decision-Making in RMS

Robert S Phillips, Bas Vaarwerk, Jessica E Morgan

Research output: Contribution to journal › Review article › peer-review

Abstract

The foundations of evidence-based practice are the triad of patient values and preferences, healthcare professional experience, and best available evidence, used together to inform clinical decision-making. Within the field of rhabdomyosarcoma, collaborative groups such as the European Paediatric Soft Tissue Sarcoma Group (EpSSG) have worked to develop evidence to support this process. We have explored many of the key research developments within this review, including patient and public involvement, decision-making research, research into areas other than drug development, core outcome sets, reporting and dissemination of research, evidence synthesis, guideline development and clinical decision rules, research of research methodologies, and supporting research in RMS.

Original language	English
Article number	66
Number of pages	9
Journal	Cancers
Volume	15
Issue number	1
DOIs	https://doi.org/10.3390/cancers15010066
Publication status	Published - 22 Dec 2022

Access to Document

10.3390/cancers15010066Licence: CC BY

cancers-15-00066
© 2022 by the authors
Final published version, 548 KBLicence: CC BY

Cite this

@article{9f50ecd6dc804e6980932949feccf8c0,

title = "Using Evidence-Based Medicine to Support Clinical Decision-Making in RMS",

abstract = "The foundations of evidence-based practice are the triad of patient values and preferences, healthcare professional experience, and best available evidence, used together to inform clinical decision-making. Within the field of rhabdomyosarcoma, collaborative groups such as the European Paediatric Soft Tissue Sarcoma Group (EpSSG) have worked to develop evidence to support this process. We have explored many of the key research developments within this review, including patient and public involvement, decision-making research, research into areas other than drug development, core outcome sets, reporting and dissemination of research, evidence synthesis, guideline development and clinical decision rules, research of research methodologies, and supporting research in RMS.",

author = "Phillips, {Robert S} and Bas Vaarwerk and Morgan, {Jessica E}",

year = "2022",

month = dec,

day = "22",

doi = "10.3390/cancers15010066",

language = "English",

volume = "15",

journal = "Cancers",

issn = "2072-6694",

publisher = "Multidisciplinary Digital Publishing Institute",

number = "1",

}

TY - JOUR

T1 - Using Evidence-Based Medicine to Support Clinical Decision-Making in RMS

AU - Phillips, Robert S

AU - Vaarwerk, Bas

AU - Morgan, Jessica E

PY - 2022/12/22

Y1 - 2022/12/22

N2 - The foundations of evidence-based practice are the triad of patient values and preferences, healthcare professional experience, and best available evidence, used together to inform clinical decision-making. Within the field of rhabdomyosarcoma, collaborative groups such as the European Paediatric Soft Tissue Sarcoma Group (EpSSG) have worked to develop evidence to support this process. We have explored many of the key research developments within this review, including patient and public involvement, decision-making research, research into areas other than drug development, core outcome sets, reporting and dissemination of research, evidence synthesis, guideline development and clinical decision rules, research of research methodologies, and supporting research in RMS.

AB - The foundations of evidence-based practice are the triad of patient values and preferences, healthcare professional experience, and best available evidence, used together to inform clinical decision-making. Within the field of rhabdomyosarcoma, collaborative groups such as the European Paediatric Soft Tissue Sarcoma Group (EpSSG) have worked to develop evidence to support this process. We have explored many of the key research developments within this review, including patient and public involvement, decision-making research, research into areas other than drug development, core outcome sets, reporting and dissemination of research, evidence synthesis, guideline development and clinical decision rules, research of research methodologies, and supporting research in RMS.

U2 - 10.3390/cancers15010066

DO - 10.3390/cancers15010066

M3 - Review article

C2 - 36612064

SN - 2072-6694

VL - 15

JO - Cancers

JF - Cancers

IS - 1

M1 - 66

ER -